IXYS Releases 250V Ultra-Junction X3-Class Power MOSFETs

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
92
IXYS Releases 250V Ultra-Junction X3-Class Power MOSFETs Offering Best-in-Class On-State Resistance and Gate Charge Figure of Merit

LEIDEN, Netherlands and MILPITAS, Calif., July 20, 2017 (GLOBE NEWSWIRE) -- IXYS Corporation (NASDAQ: IXYS ), a global manufacturer of power semiconductors and integrated circuits (ICs) for energy efficiency, power management, transportation, medical, and motor control applications, today announced a new power semiconductor product line: 250V Ultra-Junction X3-Class HiPerFET™ Power MOSFETs. With on-resistances and gate charges as low as 4.5 milliohms and 21 nanocoulombs, respectively, these devices enable highest power densities and energy efficiencies in a wide variety of high-speed power conversion applications.

Developed using a charge compensation principle and proprietary process technology, the new MOSFETs provide the best-in-class Figure of Merit (on-resistance times gate charge) which translates into lowest conduction and switching losses. They exhibit the lowest on-state resistances in the industry (5 milliohms in the TO-264 package and 4.5 milliohms in the SOT-227, for instance).

The fast intrinsic body diodes (HiPerFETs™) of the MOSFETs display very soft recovery characteristics, minimizing voltage overshoots and electromagnetic interference (EMI), especially in half or full-bridge topologies. With low reverse recovery charge and time, the diodes are capable of removing all the leftover energies during high-speed switching to avoid device failure and achieve high efficiency.

Additionally, these new devices are avalanche capable and exhibit a superior dv/dt performance.  They are robust against device failure caused by voltage spikes and accidental turn-on of parasitic bipolar transistors inherent in the MOSFET structure. As such, these rugged devices require fewer snubbers and can be used in both hard and soft switching power converters.

Well suited applications include battery chargers for light electric vehicles (LEVs), synchronous rectification in switching power supplies, motor control, DC-DC converters, uninterruptible power supplies, electric forklifts, Class-D audio amplifiers, and telecom systems.

The new 250V X3-Class Power MOSFETs with HiPerFET™ body diodes are available in the following international standard size packages: TO-3P, TO-220 (overmolded or standard), TO-247, PLUS247, TO-252, TO-263, TO-264, TO-268HV, SOT-227. Some example part numbers include IXFA60N25X3, IXFP80N25X3, IXFT170N25X3HV and IXFK240N25X3, with current ratings of 60A, 80A, 170A, and 240A, respectively.

Additional product information can be obtained by visiting the IXYS website at http://www.ixys.com  or by contacting the company directly.

About IXYS Corporation

IXYS Corporation makes and markets technology driven products to improve power conversion efficiency, generate solar and wind power, and provide efficient motor controls for industrial applications. IXYS offers a diversified product base that addresses worldwide needs for power control, electrical efficiency, renewable energy, telecommunications, medical devices, electronic displays, and RF power.

Safe Harbor Statement

Any statements contained in this press release that are not statements of historical fact, including the performance, rating, benefits, best-in-class, and suitability of products for various applications, may be deemed to be forward-looking statements.  There are a number of important factors that could cause the results of IXYS to differ materially from those indicated by these forward-looking statements, including, among others, risks detailed from time to time in the Company's SEC reports, including its Report on Form 10-K for the fiscal year ended March 31, 2017.  The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements.

Contact: Nyan Tin IXYS Corporation 1590 Buckeye Drive Milpitas, CA 95035 Tel: (408) 457-9039 Email: sales@ixys.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading